Source link : https://newshealth.biz/health-news/fda-oks-first-treatment-for-rare-kidney-disease/
March 21, 2025 — The FDA has approved a drug as the first and only treatment for adults with C3 glomerulopathy (C3G) to reduce protein in the urine. Unlike previous options that focused on symptom management, the approval marks the first treatment that targets the cause of the disease. C3G happens when an overactive immune […]
The post FDA OKs First Treatment for Rare Kidney Disease first appeared on News Health.
Author : News Health
Publish date : 2025-03-24 08:49:00
Copyright for syndicated content belongs to the linked Source.